Franco Lori

Franco Lori

UNVERIFIED PROFILE

Are you Franco Lori?   Register this Author

Register author
Franco Lori

Franco Lori

Publications by authors named "Franco Lori"

Are you Franco Lori?   Register this Author

46Publications

484Reads

48Profile Views

Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.

J Acquir Immune Defic Syndr 2013 Dec;64(4):351-9

*Division of Infectious Diseases and Center for AIDS Research, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, OH; †Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, CA; ‡Statistical and Data Analysis Center, Harvard School of Public Health, Boston, MA; §Division of Infectious Diseases and HIV Medicine, Drexel University College of Medicine, Philadelphia, PA; ‖University of Pittsburgh, Pittsburgh, PA; ¶Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD; #Department of Medicine, Rush University Medical Center, Chicago, IL; **ViroStatics srl, Sassari, Italy; ††Genetic Immunity, Budapest, Hungary; ‡‡Genetic Immunity, McLean, VA; and §§Social & Scientific Systems, Inc, Silver Spring, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0b013e3182a99590DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858388PMC
December 2013

DermaVir: a plasmid DNA-based nanomedicine therapeutic vaccine for the treatment of HIV/AIDS.

Authors:
Franco Lori

Expert Rev Vaccines 2011 Oct;10(10):1371-84

ViroStatics srl, Viale Umberto I, 07100, Sassari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erv.11.118DOI Listing
October 2011

Unsung hero Robert C. Gallo.

Authors:
Giovanni Abbadessa Roberto Accolla Fernando Aiuti Adriana Albini Anna Aldovini Massimo Alfano Guido Antonelli Courtenay Bartholomew Zvi Bentwich Umberto Bertazzoni Jay A Berzofsky Peter Biberfeld Enzo Boeri Luigi Buonaguro Franco M Buonaguro Michael Bukrinsky Arsène Burny Arnaldo Caruso Sharon Cassol Prakash Chandra Luca Ceccherini-Nelli Luigi Chieco-Bianchi Mario Clerici Sandra Colombini-Hatch Carlo de Giuli Morghen Andrea de Maria Anita de Rossi Manfred Dierich Riccardo Della-Favera Antonina Dolei Daniel Douek Volker Erfle Barbara Felber Simona Fiorentini Genoveffa Franchini Jonathan M Gershoni Frances Gotch Patrick Green Warner C Greene William Hall William Haseltine Stephens Jacobson Lars O Kallings Vaniambadi S Kalyanaraman Hermann Katinger Kamel Khalili George Klein Eva Klein Mary Klotman Paul Klotman Moshe Kotler Reinhard Kurth Alain Lafeuillade Michelangelo La Placa Jonathan Lewis Flavia Lillo Julianna Lisziewicz Anita Lomonico Lucia Lopalco Franco Lori Paolo Lusso Beatrice Macchi Michael Malim Leonid Margolis Phillip D Markham Myra McClure Nancy Miller Maria C Mingari Lorenzo Moretta Douglas Noonan Steve O'Brien Takashi Okamoto Ranajit Pal Peter Palese Amos Panet Giuseppe Pantaleo George Pavlakis Mauro Pistello Stanley Plotkin Guido Poli Roger Pomerantz Antonia Radaelli Marjorie Robertguroff Mario Roederer Mangalasseril G Sarngadharan Dominique Schols Paola Secchiero Gene Shearer Antonio Siccardi Mario Stevenson Jan Svoboda Jim Tartaglia Giuseppe Torelli Maria Lina Tornesello Erwin Tschachler Mauro Vaccarezza Angelika Vallbracht Jan van Lunzen Oliviero Varnier Elisa Vicenzi Harald von Melchner Isaac Witz Daniel Zagury Jean-Francois Zagury Giorgio Zauli Donato Zipeto

Science 2009 Jan;323(5911):206-7

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.323.5911.206DOI Listing
January 2009

IL-15 as memory T-cell adjuvant for topical HIV-1 DermaVir vaccine.

Vaccine 2008 Sep 14;26(40):5188-95. Epub 2008 Apr 14.

Research Institute for Genetic and Human Therapy (RIGHT), 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2008.03.067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582635PMC
September 2008

Fas, IL-7, and T cells: live and let die.

Authors:
Franco Lori

Blood 2008 Aug;112(4):930-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-05-156695DOI Listing
August 2008

HIV-1-specific T cell precursors with high proliferative capacity correlate with low viremia and high CD4 counts in untreated individuals.

J Immunol 2008 May;180(9):5907-15

Research Institute for Genetic and Human Therapy, Fondazione Istituto de Ricovero e Cura a Carattere Scientifico, Policlinoco San Matteo, Piazzale Golgi 2, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.180.9.5907DOI Listing
May 2008

Treating HIV/AIDS by reducing immune system activation: the paradox of immune deficiency and immune hyperactivation.

Authors:
Franco Lori

Curr Opin HIV AIDS 2008 Mar;3(2):99-103

Research Institute for Genetic and Human Therapy (RIGHT) at Cambridge, Massachusetts, USA, and Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COH.0b013e3282f525cfDOI Listing
March 2008

A checkpoint in the cell cycle progression as a therapeutic target to inhibit HIV replication.

J Infect Dis 2007 Nov 26;196(9):1409-15. Epub 2007 Sep 26.

Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/521832DOI Listing
November 2007

The potential of topical DNA vaccines adjuvanted by cytokines.

Expert Opin Biol Ther 2007 Oct;7(10):1563-74

Genetic Immunity, FO utca 68, H-1027 Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.7.10.1563DOI Listing
October 2007

Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine.

Vaccine 2007 Apr 22;25(16):3070-4. Epub 2007 Jan 22.

Research Institute for Genetic and Human Therapy (RIGHT), 4400 East-West Hwy, Suite 1126, Bethesda, MD 20814, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2007.01.024DOI Listing
April 2007

Stopping HAART temporarily in the absence of virus rebound: exploring new HIV treatment options.

Curr Opin HIV AIDS 2007 Jan;2(1):14-20

Research Institute for Genetic and Human Therapy (RIGHT) at Fondazione IRCCS Policlinico S. Matteo, 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COH.0b013e328011aad6DOI Listing
January 2007

Cytokine-adjuvanted HIV-DNA vaccination strategies.

Springer Semin Immunopathol 2006 Nov 20;28(3):231-8. Epub 2006 Oct 20.

Research Institute for Genetic and Human Therapy (RIGHT), Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00281-006-0047-yDOI Listing
November 2006

CD4+ T cell-mediated presentation of non-infectious HIV-1 virion antigens to HIV-specific CD8+ T cells.

Chin Med J (Engl) 2006 Oct;119(19):1629-38

State Key Laboratory for Infectious Diseases Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China.

View Article

Download full-text PDF

Source
October 2006

Topical DermaVir vaccine targeting dendritic cells.

Curr Drug Deliv 2006 Jan;3(1):83-8

Research Institute for Genetic and Human Therapy (RIGHT), Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156720106775197574DOI Listing
January 2006

Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanisms.

AIDS 2005 Jul;19(11):1173-81

Research Institute for Genetic and Human Therapy, IRCCS Policlinico S. Matteo, Pavia, Italy and Washington, DC 2007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.aids.0000176217.02743.d1DOI Listing
July 2005

Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency.

AIDS Res Hum Retroviruses 2005 Apr;21(4):263-72

Research Institute for Genetic and Human Therapy (RIGHT), IRCCS Policlinico S. Matteo, 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/aid.2005.21.263DOI Listing
April 2005

DermaVir, a novel HIV immunisation technology.

Vaccine 2005 Mar;23(17-18):2030-4

Research Institute for Genetic and Human Therapy, 2233 Wisconsin Ave. Suite 503, Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2005.01.004DOI Listing
March 2005

HIV DART 2004--frontiers in drug development for antiretroviral therapies. 12-16 December 2004, Montego Bay, Jamaica.

Authors:
Franco Lori

IDrugs 2005 Feb;8(2):97-9

Research Institute for Genetic and Human Therapy, 2233 Wisconsin Avenue NW, Suite 503, Washington, DC 20009, USA.

View Article

Download full-text PDF

Source
February 2005

DermaVir: a novel topical vaccine for HIV/AIDS.

J Invest Dermatol 2005 Jan;124(1):160-9

Research Institute for Genetic and Human Therapy (RIGHT), Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.0022-202X.2004.23535.xDOI Listing
January 2005

Hydroxyurea exerts a cytostatic but not immunosuppressive effect on T lymphocytes.

AIDS 2005 Jan;19(2):137-44

Research Institute for Genetic and Human Therapy at IRCCS Policlinico S. Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00002030-200501280-00005DOI Listing
January 2005

Immune reconstitution and control of HIV.

HIV Clin Trials 2004 May-Jun;5(3):170-82

The Research Institute for Genetic and Human Therapy, Policlinico San Matteo, Piazzale Golgi 2, 27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1310/QHMQ-6B3J-3D92-RC4EDOI Listing
September 2004

APC-targeted immunization for the treatment of HIV-1.

Expert Rev Vaccines 2004 Aug;3(4 Suppl):S189-98

Research Institute for Genetic and Human Therapy, IRCCS Policlinico S. Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14760584.3.4.s189DOI Listing
August 2004

Safety of hydroxyurea in the treatment of HIV infection.

Expert Opin Drug Saf 2004 Jul;3(4):279-88

Research Institute for Genetic and Human Therapy (RIGHT) at IRCCS Policlinico S. Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.3.4.279DOI Listing
July 2004

T-cell receptor excision circles (TREC) in SHIV 89.6p and SIVmac251 models of HIV-1 infection.

DNA Cell Biol 2004 Jan;23(1):1-13

Center for Neurovirology and Cancer Biology, Temple University, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/104454904322745880DOI Listing
January 2004

Hydroxyurea in the treatment of HIV infection: clinical efficacy and safety concerns.

Drug Saf 2003 ;26(9):605-24

Research Institute for Genetic and Human Therapy, Washington DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00002018-200326090-00002DOI Listing
October 2003

2nd International Symposium on Molecular Diagnostics and Skin Gene Therapy.

Expert Opin Biol Ther 2003 Jul;3(4):683-7

Research Institute for Genetic and Human Therapy, 2233 Wisconsin Ave, NW, Suite 503, Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.3.4.683DOI Listing
July 2003

Gene therapy approaches to HIV infection.

Am J Pharmacogenomics 2002 ;2(4):245-52

Research Institute for Genetic and Human Therapy at IRCCS Policlinico S. Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00129785-200202040-00004DOI Listing
May 2003

Vaccinia assay for the rapid detection of functional HIV-specific CD8+ cytotoxic T lymphocytes.

J Immunol Methods 2003 May;276(1-2):45-57

Research Institute for Genetic and Human Therapy (RIGHT), Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-1759(03)00064-4DOI Listing
May 2003

A cytostatic drug improves control of HIV-1 replication during structured treatment interruptions: a randomized study.

AIDS 2003 Jan;17(1):43-51

Infectious Diseases Unit, Clinic Institute of Infectious Diseases and Immunology, Institut d'Investigacions Biomèdiques August Pi I Sunyer, Hospital Clínic, Faculty of Medicine, University of Barcelona, Spain.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/aidsonline/2003/01030/A_cytosta
Web Search
http://dx.doi.org/10.1097/00002030-200301030-00007DOI Listing
January 2003

Therapeutic vaccination for future management of HIV/AIDS.

Vaccine 2003 Jan;21(7-8):620-3

Research Institute for Genetic and Human Therapy (RIGHT), 2233 Wisconsin Avenue NW Suite 503, Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0264-410x(02)00569-8DOI Listing
January 2003

High efficiency lentiviral gene delivery in non-dividing cells by deoxynucleoside treatment.

J Gene Med 2002 Mar-Apr;4(2):161-9

Research Institute for Genetic and Human Therapy (RIGHT) at IRCCS Policlinico San Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jgm.256DOI Listing
October 2002

Quantification of HIV-specific CD8 T cells by in vitro stimulation with inactivated viral particles.

AIDS 2002 Sep;16(14):1849-57

Research Institute for Genetic and Human Therapy (RIGHT), Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00002030-200209270-00001DOI Listing
September 2002

Structured treatment interruptions as a potential alternative therapeutic regimen for HIV-infected patients: a review of recent clinical data and future prospects.

J Antimicrob Chemother 2002 Aug;50(2):155-60

Research Institute for Genetic and Human Therapy at IRCCS Policlinico S. Matteo, P. le Golgi, 2-27100 Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkf119DOI Listing
August 2002

Control of HIV during a structured treatment interruption in chronically infected individuals with vigorous T cell responses.

HIV Clin Trials 2002 Mar-Apr;3(2):115-24

Research Institute for Genetic and Human Therapy (RIGHT) at IRCCS Policlinico S. Matteo, Pavia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1310/VFRX-6T7X-UQ2W-V0LKDOI Listing
June 2002

Methods of using interleukin 2 to enhance HIV-specific immune responses.

AIDS Res Hum Retroviruses 2002 Mar;18(4):289-93

Research Institute for Genetic and Human Therapy (RIGHT), Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/088922202753472865DOI Listing
March 2002

Structured treatment interruptions in HIV/AIDS therapy.

Microbes Infect 2002 Feb;4(2):207-14

Research Institute for Genetic and Human Therapy, IRCCS Policlinico S. Matteo, P. le Golgi, 2 - 27100, Pavia, Italy.

View Article

Download full-text PDF

Source
https://www.iasusa.org/sites/default/files/tam/14-3-107.pdf
Web Search
http://jac.oxfordjournals.org/content/50/2/155.full.pdf
Web Search
http://dx.doi.org/10.1016/s1286-4579(01)01529-5DOI Listing
February 2002